Arrowstreet Capital, Limited Partnership Gossamer Bio, Inc. Transaction History

Arrowstreet Capital, Limited Partnership

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$5.97 - $9.97 $210,460 - $351,472	-35,253 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$8.44 - $12.49 $297,535 - $440,309	35,253 New	35,253 $306,000
Q4 2020 Feb 12, 2021	SELL	$8.3 - $13.59 $898,358 - $1.47 Million	-108,236 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$11.3 - $14.75 $318,750 - $416,068	28,208 Added 35.25%	108,236 $1.34 Million
Q2 2020 Aug 12, 2020	BUY	$9.52 - $15.98 $641,914 - $1.08 Million	67,428 Added 535.14%	80,028 $1.04 Million
Q1 2020 May 15, 2020	SELL	$8.0 - $15.48 $1.02 Million - $1.97 Million	-127,252 Reduced 90.99%	12,600 $128,000
Q4 2019 Feb 13, 2020	BUY	$14.82 - $26.79 $2.07 Million - $3.75 Million	139,852 New	139,852 $2.19 Million

109

167M

430K

519K

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $84.6M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.